Medical Research Highlights

Sensigent’s eNose instrumentation, sensors and algorithms have been at the forefront of clinical research for many years, including screening tests for lung cancer and COVID-19. These and other exciting results have been documented in over 250 papers from leading research hospitals and other institutions worldwide citing the Cyranose 320 and MSEM 160 to screen for conditions from lung cancer, COPD/asthma, respiratory infections, to IBD, Crohn’s, GI and UT infections. These papers have cited potential roles for the NoseChip® sensor array in diabetes care, cardiac care and several types of cancer with high accuracy in many cases (NPV>90%, PPV>80%). Rapid and minimally-invasive measurement of volatile compounds (gases and VOCs) is made directly from breath, urine, fecal, skin and culture samples. CONTACT USfor the latest information on medical research underway with Sensigent’s NoseChip sensor arrays and our Cyranose and MSEM instruments.